The Virtual Hamilton FHT Pharmacist

Thursday, March 8, 2012

Opioid Conversion






Posted by Antony Gagnon at 7:35 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Search This Blog

Popular Posts

  • Clinical Aspects of Hypoglycemia in Diabetes – Consequences and Prevention
  • Omega-3 Fatty Acids & CV outcomes in patients with dysglycemia
    Clinical Question In patients at high risk for cardiovascular events and have impaired fasting glucose, impaired glucose tolerance, or diab...
  • Diagnosis of Diabetes
    Did you know that A1C > or = 6.5% using a standardized, validated assay, in the absence of conditions that affect the accuracy of the A1C...
  • Caring for Patients with Dementia and Diabetes
    ADA 2012 Conference, presented by Jamehl Demons, MD -        Diabetes – Risk factor for cognitive impairment o    Known risk factors...

Followers

Blog Archive

  • ▼  2012 (15)
    • ►  October (1)
    • ►  August (6)
    • ►  July (3)
    • ►  June (1)
    • ▼  March (1)
      • Opioid Conversion
    • ►  February (1)
    • ►  January (2)
  • ►  2011 (8)
    • ►  November (4)
    • ►  September (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)

Contributors

  • Antony Gagnon
  • Catherine Bednarowski
  • Hamilton FHT pharmacists
Hamilton FHT 2011. Watermark theme. Powered by Blogger.